Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-sirolimus + letrozole in endometrioid endometrial cancer
NCT05997017Phase 2Recruiting
- Sponsor
- Aadi Bioscience, Inc.
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in endometrioid endometrial cancer, sponsored by Aadi Bioscience, Inc.. Started Dec 2023; status: recruiting.
02
Drugs
sirolimus
03
Conditions
endometrioid endometrial cancer
Beyond the preview
Go deeper on NCT05997017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05997017.